Sanofi | SAN

Stock Price
79.50
Daily Change
0.54 0.68%
Monthly
-1.66%
Yearly
-24.83%
Q3 Forecast
78.92

Peers Price Chg Day Year Date
AbbVie 212.56 -0.44 -0.21% 9.95% Sep/05
Aena 24.41 0.11 0.45% 31.95% Sep/06
Alcon AG 64.08 0.62 0.98% -19.15% Sep/05
Almirall 10.96 -0.16 -1.44% 27.89% Sep/05
Amgen 283.64 3.54 1.26% -11.49% Sep/05
Amarin 15.33 0.30 2.00% 27.64% Sep/05
AstraZeneca 12,090.00 -98.00 -0.80% -4.89% Sep/06
Bayer 28.16 -0.42 -1.47% -1.83% Sep/06
Biogen 140.67 0.73 0.52% -30.02% Sep/05
BMW 88.44 -0.16 -0.18% 13.91% Sep/06
Bristol-Myers Squibb 47.14 0.45 0.96% -3.28% Sep/05
Mercedes-Benz AG 52.92 -0.19 -0.36% -9.46% Sep/05
Vinci 115.55 -0.35 -0.30% 5.24% Sep/06
Essilor 259.60 -0.60 -0.23% 22.74% Sep/06
Fresenius Medical Care 41.99 0.28 0.67% 16.83% Sep/06
Fresenius 46.82 -0.36 -0.76% 39.22% Sep/06
Genmab 1,751.50 6.50 0.37% -5.83% Sep/05
Gilead Sciences 115.05 2.28 2.02% 46.10% Sep/05
Galapagos 28.44 1.84 6.92% 11.53% Sep/06
GRIFOLS 12.30 0.02 0.16% 32.17% Sep/05
GlaxoSmithKline 1,476.00 7.00 0.48% -10.63% Sep/05
Hikma Pharmaceutical 1,720.00 -3.00 -0.17% -12.07% Sep/05
J&J 178.43 -0.33 -0.18% 8.51% Sep/05
Eli Lilly 727.21 -15.70 -2.11% -19.48% Sep/05
Lonza 577.40 -0.80 -0.14% 7.68% Sep/05
Merck 109.55 1.05 0.97% -35.52% Sep/06
Merck 84.71 0.66 0.79% -28.14% Sep/05
Novartis 103.98 0.06 0.06% 5.46% Sep/05
Novo Nordisk A/S 350.00 -10.50 -2.91% -60.30% Sep/05
Orion 65.90 -1.10 -1.64% 36.67% Sep/05
Pfizer 24.88 0.34 1.39% -12.95% Sep/05
Philips 23.80 0.02 0.08% -12.63% Sep/06
Recordati 54.05 -0.25 -0.46% 5.16% Sep/05
Regeneron Pharmaceuticals 573.38 6.16 1.09% -49.30% Sep/05
Roche Holding 274.20 -1.50 -0.54% 2.62% Sep/06
Sanofi 79.50 0.54 0.68% -24.83% Sep/06
SAP 228.25 -4.95 -2.12% 18.52% Sep/06
UCB 206.90 2.30 1.12% 28.99% Sep/05
Volkswagen 99.92 0.82 0.83% 8.89% Sep/06

Indexes Price Day Year Date
EU50 5318 -28.56 -0.53% 12.24% Sep/05
FR40 7675 -24.14 -0.31% 4.39% Sep/05
EU100 1582 -4.83 -0.30% 9.89% Sep/05
EU600 549 -0.88 -0.16% 8.42% Sep/05

Sanofi traded at 79.50 this Saturday September 6th, increasing 0.54 or 0.68 percent since the previous trading session. Looking back, over the last four weeks, Sanofi gained 1.66 percent. Over the last 12 months, its price fell by 24.83 percent. Looking ahead, we forecast Sanofi to be priced at 78.92 by the end of this quarter and at 77.20 in one year, according to Trading Economics global macro models projections and analysts expectations.

Sanofi SA is a healthcare company based in France. The Company focuses on patient needs and engages in the research, development, manufacture, and marketing of therapeutic solutions. Its three operating segments are: Pharmaceuticals, Consumer Healthcare (CHC), and Vaccines. The Pharmaceuticals includes: Immunology, Multiple Sclerosis / Neurology, Oncology, Rare Diseases, Rare Blood Disorders, Cardiovascular, Diabetes, Established Prescription Products. The Vaccines segment comprises, for all geographical territories, the commercial operations of Sanofi Pasteur, together with research, development, and production activities dedicated to vaccines. The CHC segment comprises the commercial operations for Sanofi’s Consumer Healthcare products, together with research, development and production activities dedicated to those products. The Company’s products developed in collaboration or franchise include Dupixent, Aubagio, Lemtrada, Cerezyme, Lumizyme, Jevtana, Fabrazyme, among others.